The seemingly paradoxical but ineffective increase in p16INK4a, a cyclin-dependent kinase inhibitor [10], coincides with E7 expression in our cases of oropharyngeal carcinoma [1]. This evidence concerns the gene CDKN2A and oropharyngeal carcinoma.